A predictive and prognostic model for surgical outcome and prognosis in ovarian cancer computed by clinico-pathological and serological parameters (CA125, HE4, mesothelin)

被引：0
|
作者：
Kuhlmann, J. D. [1 ,2 ]
Klotz, B. M. [1 ,2 ]
Link, T. [1 ,2 ]
Wimberger, P. [1 ,2 ]
机构：
[1] Tech Univ Dresden, Dept Gynecol & Obstet, Med Fac, Dresden, Germany
[2] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dresden, Germany
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2023年 / 83卷 / 06期
关键词：
D O I：
10.1055/s-0043-1769870
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
61
引用
收藏
页码：E32 / E33
页数：2
相关论文
共 50 条
  • [1] A predictive and prognostic model for surgical outcome and prognosis in ovarian cancer computed by clinico-pathological and serological parameters (CA125, HE4, mesothelin)
    Klotz, Daniel Martin
    Link, Theresa
    Wimberger, Pauline
    Kuhlmann, Jan Dominik
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2024, 62 (03) : 530 - 539
  • [2] Defining a prognostic risk score in ovarian cancer patients by integrated analysis of serum mesothelin, HE4, CA125 and surgical outcome.
    Wimberger, Pauline
    Klotz, Daniel
    Goeckenjan, Maren
    Link, Theresa
    Kuhlmann, Jan Dominik
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E17611 - E17611
  • [3] HE4 AND CA125 IN OVARIAN CANCER PATIENTS
    Kotowicz, B.
    Fuksiewicz, M.
    Kowalska, M.
    Sobiczewski, P.
    Skrzypczak, M.
    Spiewankiewicz, B.
    Kaminska, J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [4] THE DIAGNOSTIC AND PROGNOSTIC VALUE OF HE4 AND CA125 IN OVARIAN CANCER PATIENTS
    Korse, Catharina M.
    Bonfrer, J. M. G.
    van Beurden, M.
    TUMOR BIOLOGY, 2010, 31 : S111 - S111
  • [5] Diagnostic and Prognostic Significance of CA125 and HE4 in Ovarian Cancer Patients
    Bandiera, E.
    Romani, C.
    Specchia, C.
    Zanotti, L.
    Belloli, S.
    Bignotti, E.
    Tassi, R. A.
    Tognon, G.
    Pecorelli, S.
    Ravaggi, A.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S539 - S539
  • [6] Serum HE4 superior to CA125 in predicting poorer surgical outcome of epithelial ovarian cancer
    Shen, Ying
    Li, Li
    TUMOR BIOLOGY, 2016, 37 (11) : 14765 - 14772
  • [7] CA125 and HE4: Measurement Tools for Ovarian Cancer
    Zhao, Tingting
    Hu, Weiping
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2016, 81 (05) : 430 - 435
  • [8] The diagnosis and pathological value of combined detection of HE4 and CA125 for patients with ovarian cancer
    Zheng, Li-e
    Qu, Jun-ying
    He, Fei
    OPEN MEDICINE, 2016, 11 (01): : 125 - 132
  • [9] Influence of Ovarian Cancer Risk Status on the Diagnostic Performance of the Serum Biomarkers Mesothelin, HE4, and CA125
    Shah, Chirag A.
    Lowe, Kimberly A.
    Paley, Pamela
    Wallace, Erin
    Anderson, Garnet L.
    McIntosh, Martin W.
    Andersen, M. Robyn
    Scholler, Nathalie
    Bergan, Lindsay A.
    Thorpe, Jason D.
    Urban, Nicole
    Drescher, Charles W.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (05) : 1365 - 1372
  • [10] Early diagonosis of ovarian cancer: serum HE4, CA125 and ROMA model
    Wang, Haixia
    Liu, Pingping
    Xu, Hai
    Dai, Hongmei
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (12): : 14141 - 14148
12345